LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products

14/09/2023

POSITION PAPER

Brussels,12 September 2023

EuropaBio welcomes the Revision of the Detergents Regulation. This is a positive development in supporting access to market for innovative products, in line with the EU Chemicals Strategy for Sustainability and overall EU Green Deal objectives for sustainability.
We support revision of the following points in annex II on microbial based cleaning products (MBCPs) to ensure that requirements are risk-based considering the safety, efficacy, and sustainability profile of products:

− Annex II, point 1:
o Microorganisms should be fully identifiable, but it is not necessary to specify the American Type Culture Collection (ATCC) when there are several other well-established culture collections.
o For identification purposes, the requirement for 16s ribosomal DNA should be replaced with a more reliable identification method such as Whole Genome Sequencing.
o The microorganisms used should be safe, even if not present on the Risk Group I or QPS list.

− Annex II, point 2: We fully agree to the exclusion list of pathogens in the final product but the reference to strain in the text is incorrect and should be deleted. The final product shall be free of pathogenic microorganisms.

− Annex II, point 3: The primary focus should be to assess the safety of genetically modified microorganisms deliberately released into the environment, rather than completely excluding their use in detergents. The text should be amended to include a reference to Directive 2001/18/EC on deliberate release of genetically modified microorganisms into the environment which provides guidance on the preparation of an environmental risk assessment (ERA) and on the establishment of an environmental monitoring plan.

− Annex II, point 6:
o There should not be an additional requirement for minimum shelf life for MBCPs compared to conventional detergents. This requirement should be amended to include that the product is stable for the declared period of shelf life.
o Delete the requirement of <10% microbial count decrease. The key requirement should be that the product is stable for the declared period of shelf life.

− Annex II, point 7: Animal tests should only be performed as a last resort, particularly where other tests can provide information to address concerns. The text should be amended to include this nuance and prioritize other tests such as immune tests or particle size distribution measurements.

− Annex II, point 9 and 11: Producers should be able to perform tests related to functionality and marketing claims themselves, rather than requiring an external lab. This requirement should be removed.

− Annex V, point 6(a): Further clarification and guidance is needed for the point on ‘surfaces in contact with food’. This point shall be amended to refer to “instructions or special precautions, where relevant” to address safety concerns.

Revision of the Detergents Regulation: EuropaBio policy asks for Microbial-based Cleaning Products


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
25/06/2025

Hawkwood Biotech joins EuropaBio: Supporting Industrial Biotech with their Critical Challenges


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.